These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7570141)

  • 1. The anatomy of the basal ganglia and Parkinson's disease: a review.
    Lee TK; Chau R; Leong SK
    Singapore Med J; 1995 Feb; 36(1):74-6. PubMed ID: 7570141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia.
    Marino MJ; Awad H; Poisik O; Wittmann M; Conn PJ
    Amino Acids; 2002; 23(1-3):185-91. PubMed ID: 12373536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease: unanswered questions.
    Calne DB; Kebabian JK
    J Neural Transm Suppl; 1980; (16):1-5. PubMed ID: 6933216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease.
    Guridi J; Luquin MR; Herrero MT; Obeso JA
    Mov Disord; 1993 Oct; 8(4):421-9. PubMed ID: 8232351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Function of cortical basal nuclei: Pathophysiology of Parkinson's disease].
    Takakusaki K
    Nihon Seirigaku Zasshi; 2003; 65(4-5):113-29. PubMed ID: 12884733
    [No Abstract]   [Full Text] [Related]  

  • 6. Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease.
    Starr MS
    Synapse; 1995 Apr; 19(4):264-93. PubMed ID: 7792721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease.
    Brown P
    Mov Disord; 2003 Apr; 18(4):357-63. PubMed ID: 12671940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathophysiology of motor symptoms in Parkinson's disease.
    Santens P; Boon P; Van Roost D; Caemaert J
    Acta Neurol Belg; 2003 Sep; 103(3):129-34. PubMed ID: 14626691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The basal ganglia in Parkinson's disease: current concepts and unexplained observations.
    Obeso JA; Marin C; Rodriguez-Oroz C; Blesa J; Benitez-Temiño B; Mena-Segovia J; Rodríguez M; Olanow CW
    Ann Neurol; 2008 Dec; 64 Suppl 2():S30-46. PubMed ID: 19127584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 300-Hz subthalamic oscillations in Parkinson's disease.
    Foffani G; Priori A; Egidi M; Rampini P; Tamma F; Caputo E; Moxon KA; Cerutti S; Barbieri S
    Brain; 2003 Oct; 126(Pt 10):2153-63. PubMed ID: 12937087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease.
    Kopell BH; Rezai AR; Chang JW; Vitek JL
    Mov Disord; 2006 Jun; 21 Suppl 14():S238-46. PubMed ID: 16810674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new history of basal ganglia and physiopathology of Parkinson's disease].
    Reinoso Suárez F
    An R Acad Nac Med (Madr); 2001; 118(4):771-88; discussion 788-92. PubMed ID: 12056254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease.
    Kerkerian-Le Goff L; Bacci JJ; Jouve L; Melon C; Salin P
    Brain Res Bull; 2009 Feb; 78(2-3):80-4. PubMed ID: 18790021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease.
    Strange PG
    Mov Disord; 1993 Jul; 8(3):263-70. PubMed ID: 8101967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for a role of the caudal intralaminar nuclei in the pathophysiology of Parkinson's disease.
    Lanciego JL; López IP; Rico AJ; Aymerich MS; Pérez-Manso M; Conte L; Combarro C; Roda E; Molina C; Gonzalo N; Castle M; Tuñón T; Erro E; Barroso-Chinea P
    Brain Res Bull; 2009 Feb; 78(2-3):55-9. PubMed ID: 18790023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa delivery systems for the treatment of Parkinson's disease: an overview.
    Goole J; Amighi K
    Int J Pharm; 2009 Oct; 380(1-2):1-15. PubMed ID: 19651197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
    Braak H; Del Tredici K
    Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brainstem interactions with the basal ganglia.
    Redgrave P; Coizet V
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S301-5. PubMed ID: 18267254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.